Internal Medicine · Russellville, KY
NPI
1902885759
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1405 Nashville St
Russellville, KY, 42276
Phone (270) 725-9700
Groups this clinician bills Medicare through
Medicare paid, 2024
$372K
16,755 services
Medicare patients, 2024
670
Average age 75
Drug cost, 2024
$2.6M
23,547 prescriptions
Company payments, 2025
$711
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kamal P Singh was code J0897 (injection, denosumab, 1 mg), 2,461 times for 28 patients. In total Kamal P Singh billed 16,755 services in 182 codes, and Medicare paid $372K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,461 | 28 | $20.27 | $50K |
| 99214 Office E&M - Established | Office | 1,426 | 514 | $82.25 | $117K |
| 80053 Clinical Chemistry | Office | 619 | 489 | $10.34 | $6,399 |
| 85025 Blood Count | Office | 616 | 488 | $7.61 | $4,688 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 598 | 379 | $12.58 | $7,522 |
| 80061 Clinical Chemistry | Office | 585 | 481 | $13.10 | $7,662 |
| 83036 Blood Count | Office | 574 | 477 | $9.52 | $5,464 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 361 | 68 | $41.27 | $15K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 360 | 20 | $0.09 | $30.87 |
| 96372 Injection Administration | Office | 285 | 98 | $9.64 | $2,747 |
| 82043 Clinical Chemistry | Office | 247 | 210 | $5.66 | $1,398 |
| 82570 Clinical Chemistry | Office | 244 | 207 | $5.08 | $1,240 |
| 82306 Clinical Chemistry | Office | 244 | 220 | $28.89 | $7,049 |
| 82607 Clinical Chemistry | Office | 239 | 224 | $14.70 | $3,514 |
| 99457 E&M - Miscellaneous | Office | 213 | 46 | $35.77 | $7,620 |
By year: 2022 $589K for 22,816 services; 2023 $608K for 26,089 services; 2024 $372K for 16,755 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 619 | 489 | $10.34 | $6,399 |
| 85025 Blood Count | 616 | 488 | $7.61 | $4,688 |
| 80061 Clinical Chemistry | 585 | 481 | $13.10 | $7,662 |
| 83036 Blood Count | 574 | 477 | $9.52 | $5,464 |
| 82043 Clinical Chemistry | 247 | 210 | $5.66 | $1,398 |
| 82306 Clinical Chemistry | 244 | 220 | $28.89 | $7,049 |
| 82570 Clinical Chemistry | 244 | 207 | $5.08 | $1,240 |
| 82607 Clinical Chemistry | 239 | 224 | $14.70 | $3,514 |
| 87804 Immunoassay | 207 | 92 | $16.22 | $3,357 |
| 84443 Clinical Chemistry | 111 | 103 | $16.46 | $1,827 |
Medicare prescription drug claims, 2024
In 2024, the drug Kamal P Singh prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,117 prescriptions and refills. In total Kamal P Singh wrote 23,547 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,117 | 2,729 | 280 | $9,948 |
| Atorvastatin Calcium Generic | 947 | 2,275 | 225 | $5,800 |
| Levothyroxine Sodium Generic | 773 | 1,879 | 175 | $7,028 |
| Metoprolol Succinate Generic | 772 | 1,787 | 187 | $8,936 |
| Pantoprazole Sodium Generic | 757 | 1,756 | 208 | $7,105 |
| Amlodipine Besylate Generic | 736 | 1,768 | 187 | $2,986 |
| Lisinopril Generic | 732 | 1,914 | 194 | $3,474 |
| Montelukast Sodium Generic | 562 | 1,174 | 122 | $3,857 |
| Metoprolol Tartrate Generic | 520 | 1,284 | 134 | $2,603 |
| Omeprazole Generic | 477 | 1,132 | 118 | $3,571 |
| Losartan Potassium Generic | 409 | 1,079 | 115 | $4,454 |
| Furosemide Generic | 370 | 753 | 99 | $1,080 |
| Hydrochlorothiazide Generic | 353 | 901 | 92 | $1,114 |
| Eliquis Apixaban | 343 | 517 | 73 | $288K |
| Meloxicam Generic | 338 | 707 | 79 | $1,401 |
Brand drugs: 3,299 claims; generic drugs: 20,041 claims; opioid claims: 100.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kamal P Singh $711 ($711 in general payments such as food, travel and fees) from 12 companies. The largest payer was Amgen Inc. with $217.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 10 | $217 |
| Boston Scientific Corporation BSX | 2 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $84.29 |
| Novo Nordisk Inc NVO | 3 | $61.76 |
| Corcept Therapeutics CORT | 3 | $53.86 |
| GlaxoSmithKline, LLC. GSK | 3 | $46.93 |
| Globus Medical, Inc. GMED | 2 | $44.84 |
| Dexcom, Inc. DXCM | 1 | $29 |
| Exact Sciences Corporation EXAS | 1 | $16.65 |
| Merck Sharp & Dohme LLC MRK | 1 | $15.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.